Br J Clin Pharmacol 23: 545-55 1

Author(s): Somogyi A, Stockley C, Keal J, Rolan P, Bockner F (1 987) Reduction of metformin renal tubular secretion by cimetidine in man

Abstract

To determine whether cimetidine altered the renal handling of metformin, seven subjects took 0.25 g metformin daily with and without cimetidine 0.4 g twice daily. Blood and urine samples were collected and assayed for metformin, cimetidine and creatinine by h.p.l.c. Cimetidine significantly increased the area under the plasma metformin concentration-time curve by an average of 50% and reduced its renal clearance over 24 h by 27% (P less than 0.008). There was no alteration in the total urinary recovery of metformin when cimetidine was co-administered. The effect of cimetidine on the renal clearance of metformin was time dependent, being significantly reduced up to 6 h following cimetidine. These results appeared to be consistent with competitive inhibition of renal tubular secretion. Cimetidine had no effect on the renal clearance of creatinine, but time-dependent variations in both metformin and creatinine renal clearance were observed. Metformin had no effect on cimetidine disposition. It is concluded that cimetidine inhibits the renal tubular secretion of metformin in man, resulting in higher circulating plasma concentrations. Because of its propensity for causing dose and concentration-dependent adverse effects, the dose of metformin should be reduced when cimetidine is co-prescribed.

Similar Articles

National standards for diabetes self-management education

Author(s): Mensing C, Boucher J, Cypress M, Weinger K, Mulcaby K, et al.

The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes

Author(s): Parving HH, Lehnert H, Bröchner-Mortensen J, Gomis R, Andersen S, et al.

Am Fam Phys 55: 817-824

Author(s): Baliga BS, Fonseca VA (l997) Recent advances in the treatment of type II diabetes mellitus

Metformin

Author(s): Bailey CJ, Turner RC

Incidence of lactic acidosis in metformin users

Author(s): Stang M, Wysowski DK, Butler-Jones D

Profiles of people with type 2 diabetes mellitus

Author(s): Savoca MR, Miller CK, Quandt SA

Phenformin-induced lactic acidosis precipitated by tetracycline

Author(s): Arc A, Korhonen T, Halinen M

Oral hypoglycemic agents in type II diabetes mellitus

Author(s): Lubbos H, Miller JL, Rose LI

Primary care diabetes

Author(s): Yeap BB

Ann Pharmacother 30: 20-26

Author(s): Kubacka RT, Antal EJ, Juhi RP, Weishman IR (1 996) Effects of aspirin and ibuprofen on the pharmacokinetics and pharmacodynamics of glyburide in healthy subjects

Suiphaphenazole-induced hypoglycaemic attacks in tolbutamide-treated diabetics

Author(s): Christensen LK, Hansen J, Kristensen M

Drug-induced hypoglycemic coma in 102 diabetic patients

Author(s): Ben-Ami H, Nagachandran P, Mendelson A, Edoute Y

Attitudes and beliefs about exercise among persons with non-insulin dependent diabetes

Author(s): Swift CS, Armstrong JE, Berman KA, Cambell RK, Pond-Smith D

Nursing Research: Principle and Methods (7thedn)

Author(s): Polit DF, Hungler BP

The role of self monitoring of blood glucose in the care of people with diabetes: report of global consensus conference

Author(s): Bergenstal RM, Gavin JR, Global Consensus conference on Glucose monitoring panel

Self-monitoring of blood glucose among diabetes patients attending government health clinics

Author(s): Mastura I, Mimi O, Piterman L, Teng CL, Wijesinha S

Ethnicity and glycaemic control are major determinants of diabetic dyslipidaemia in Malaysia

Author(s): Ismail IS, Nazaimoon W, Mohamad W, Letchuman R, Hew FL, et al.

Therapeutic benefits of ACE inhibitors and other antihypertensive drugs in patients with type 2 diabetes

Author(s): Pahor M, Psaty BM, Alderman MH, Applegate WB, Williamson JD, et al.

Using intake biomarkers to evaluate the extent of dietary misreporting in a large sample of adults: the OPEN study

Author(s): Subar AF, Kipnis V, Troiano RP, Midthune D, Schoeller DA, et al.

Nutrition recommendations and interventions for diabetes--2006: a position statement of the American Diabetes Association

Author(s): Bantle JP, Wylie-Rosett J, Albright AL, Apovian CM, Clark NG, et al.

The Dietician challenge: the implementation of nutritional advice for people with diabetes

Author(s): Nutrition sub-committee of the diabetes Care Advisory Committee of Diabetes UK

The epidemic of obesity

Author(s): Stein CJ, Colditz GA

Clinic based support to help overweight patients with type 2 diabetes increase physical activity and loss weight

Author(s): Christian JG, Bessesen DH, Byers TE, Christian KK, Goldstein MG, et al.

Self-help weight loss versus a structured commercial program after 26 week: a randomized controlled study

Author(s): Heshka S, Greenway F, Anderson JW, Atkinson RL, Hill JO, et al.

Patient education in the management of diabetes mellitus

Author(s): Tan SL, Yong LS, Wan S, Wong ML

Structured patient education: the diabetes X-PERT programme makes a difference

Author(s): Deakin T, Cade J, Williams R, Greenwood D

A taxanomy of diabetes educational intervention

Author(s): Elasy T, Ellis S, Brown A, Pichert J

Patient adherence improves glycaemic control

Author(s): Rhee MK, Slocum W, Ziemer DC, Culler SD, Cook CB, et al.

The pharmacy Diabetes Care Program: assessment of a community pharmacy diabetes service model in Australia

Author(s): Krass I, Armour CL, Mitchell B, Brilliant M, Dienaar R, et al.

Self-monitoring of blood glucose in patients with type 2 diabetes who are not using insulin

Author(s): Welschen LM, Bloemendal E, Nijpels G, Dekker J, Heine RJ, et al.

Access to transportation and health care utilization in a rural region

Author(s): Arcury TA, Preisser JS, Gesler WM, Powers JM

Driving distance as a barrier to glycaemic control in diabetes

Author(s): Strauss K, MacLean C, Troy A, Littenberg B

The use of text messaging to improve attendance in primary care: a randomized controlled trial

Author(s): Leong KC, Chen WS, Leong KW, Mastura I, Mimi O, et al.